ARV Technologies


Advanced RNA Vaccine Technologies (ARV Technologies) is a Maryland, USA and Suzhou, China based biotechnology company passionate about innovating safer and more efficient RNA preventive vaccines for infectious diseases and therapeutic vaccines for cancer. Founded in 2021, the ARV team dedicates their time to focus on mRNA vaccine research and optimizing their lipid nanoparticle delivery technology in order to create safer and more efficient vaccines for human health. They have developed platforms for both human and animal applications with three patents filed and two more in preparation.